Publications by authors named "James Magner"

Claim this Profile
H
High Thyroid Cancer Mortality Rate in Japan: A Result of Nonaggressive Treatment Strategy, or Just an Aging Population?
James A Magner

Thyroid· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unique obstacles to establishing thyroid cancer registries.
Elizabeth N Pearce, Stephanie L Lee, Richard Weiss, James Magner, Jeffrey R Garber

J Clin Transl Endocrinol· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reassessing the NTCTCS Staging Systems for Differentiated Thyroid Cancer, Including Age at Diagnosis.
Donald S A McLeod, Jacqueline Jonklaas, James D Brierley, Kenneth B Ain, David S Cooper, James Magner

Thyroid· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Outcomes Following Therapy in Differentiated Thyroid Carcinoma: NTCTCS Registry Analysis 1987-2012.
Aubrey A Carhill, Danielle R Litofsky, Douglas S Ross, Jacqueline Jonklaas, David S Cooper, James Magner

J Clin Endocrinol Metab· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serial measurements of serum thyroglobulin in response to recombinant human thyrotropin stimulation.
Richard Weiss, James Magner

Thyroid· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thyrotropin in San Diego: echoes after nearly a century.
James Magner

Thyroid· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Historical note: many steps led to the 'discovery' of thyroid-stimulating hormone.
James Magner

Eur Thyroid J· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term efficacy of modified-release recombinant human thyrotropin augmented radioiodine therapy for benign multinodular goiter: results from a multicenter, international, randomized, placebo-controlled, dose-selection study.
Søren Fast, Laszlo Hegedüs, Furio Pacini, Aldo Pinchera, Angela M Leung, James Magner

Thyroid· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-risk patients with differentiated thyroid cancer T4 primary tumors achieve remnant ablation equally well using rhTSH or thyroid hormone withdrawal.
Peter Bartenstein, Elisa Caballero Calabuig, Carlo Ludovico Maini, Renzo Mazzarotto, M Angustias Muros de Fuentes, James Magner

Thyroid· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognosis of differentiated thyroid cancer in relation to serum thyrotropin and thyroglobulin antibody status at time of diagnosis.
Donald S A McLeod, David S Cooper, Paul W Ladenson, Kenneth B Ain, James D Brierley, James Magner

Thyroid· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Introduction to the recombinant human TSH (rhTSH) symposium articles.
Lewis E Braverman, James A Magner

Endocr Pract· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recombinant human thyrotropin to help confirm lack of evidence of radiation-induced differentiated thyroid cancer in young women seeking pregnancy.
Valentina Drozd, Tatjana Leonova, Tatjana Mitjukova, Maxim Lushchik, Sergey Koritko, James A Magner

Nucl Med Rev Cent East Eur· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radioiodine therapy in patients with stage I differentiated thyroid cancer.
Jacqueline Jonklaas, David S Cooper, Kenneth B Ain, Thomas Bigos, James D Brierley, James Magner

Thyroid· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recurrence after treatment of micropapillary thyroid cancer.
Douglas S Ross, Danielle Litofsky, Kenneth B Ain, Thomas Bigos, James D Brierley, James Magner

Thyroid· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Problems associated with the use of thyrogen in patients with a thyroid gland.
James Magner

N Engl J Med· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of various doses of recombinant human thyrotropin in patients with multinodular goiters.
Lewis Braverman, Richard T Kloos, Bill Law, Mark Kipnes, Michelle Dionne, James Magner

Endocr Pract· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Seymour D. Van Meter, M.D. (1865-1934): the Texan who wielded a scalpel in Denver and left a lasting legacy.
James A Magner

Thyroid· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of patients with differentiated thyroid carcinoma following initial therapy.
Jacqueline Jonklaas, Nicholas J Sarlis, Danielle Litofsky, Kenneth B Ain, S Thomas Bigos, James Magner

Thyroid· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recombinant human thyrotropin-assisted radioiodine therapy for patients with metastatic thyroid cancer who could not elevate endogenous thyrotropin or be withdrawn from thyroxine.
Richard J Robbins, Albert Driedger, James Magner,

Thyroid· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis